PTC Therapeutics, Inc. Share Price

PTC Therapeutics, Inc. Share Price

NASDAQ: PTCT | Mid Cap
$64.94
+$1.96 (3.12%) Last updated on 29 Oct, 2026 | 19:54 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

PTC Therapeutics, Inc. Stock Performance

Open
$64.06
Prev. Close
$62.98
Circuit Range
N/A
Day Range
$64.06 - $65.00
Year Range
$58.80 - $90.79
Volume
5,025
Average Traded
$64.64

PTC Therapeutics, Inc. Share Price Today

As of 29 October 2026, PTC Therapeutics, Inc.'s share price is $64.94. The stock opened at $64.06, compared to its previous close of $62.98. During today's trading session, PTC Therapeutics, Inc.'s share price traded between $64.06 and $65.00, with an average price of $64.53. Over the past 52 weeks, the stock has recorded a high of $90.79 and a low of $58.80. In terms of performance, PTC Therapeutics, Inc.'s share price has declined by 0.21% over the last six months and is down 4.90% on a year-on-year basis.

PTC Therapeutics, Inc. Share Price Chart

Line chart of the PTC Therapeutics, Inc. price trend over the selected period. The price rose overall, ranging from 63.33 to 64.94, ending at 64.94.
$64.06$65.00
L
Show Current Price
H

PTC Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$5.17B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.46
Revenue (TTM)
$1.73T
Return On Equity (TTM)
23.21%
Profit Margin
39.44%
Debt to Equity
-3.61
Quarterly Earnings Growth YoY
425.16%

PTC Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$211.01$164.68$272.55$360.52
Net Profit$15.90-$134.97-$2.81$83.50
Net Profit Margin7.54%-81.96%-1.03%23.16%
Income ChangeN/A-948.87%97.92%3071.53%

PTC Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$698.80$937.82$806.78$1730.66
Net Profit-$559.02-$626.60-$363.30$682.64
Net Profit Margin-80.00%-66.81%-45.03%39.44%
Income ChangeN/A-12.09%42.02%287.90%

About PTC Therapeutics, Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

PTC Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$64.38
$64.94
+0.11%
Sep 2026
$69.54
$64.87
-9.56%
Aug 2026
$67.65
$71.73
+5.51%
Jul 2026
$82.55
$67.98
-16.61%
Jun 2026
$73.08
$81.53
+10.34%
May 2026
$65.60
$73.89
+13.54%
Apr 2026
$69.56
$65.08
-4.44%
Mar 2026
$67.37
$68.11
-0.14%
Feb 2026
$75.63
$68.20
-9.73%
Jan 2026
$75.66
$75.55
-0.55%
Dec 2025
$83.81
$75.97
-11.57%
Nov 2025
$68.99
$85.91
+25.80%

PTCT Share Price FAQs